Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoid Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00003113
What this trial is testing

Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas

Who this might be right for
Lymphoma
Case Comprehensive Cancer Center 6
Early research (Phase 1)Looking for participantsNCT06909474
What this trial is testing

Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic Malignancies

Who this might be right for
T-ALL/Lymphoma
Chongqing Precision Biotech Co., Ltd 15
Not applicableActive Not RecruitingNCT06198010
What this trial is testing

A Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors

Who this might be right for
Hematopoietic and Lymphoid System NeoplasmMalignant Solid NeoplasmHematopoietic and Lymphatic System Neoplasm
Mayo Clinic 680
Testing effectiveness (Phase 2)Study completedNCT00476190
What this trial is testing

ALL Adult Consortium Trial: Adult ALL Trial

Who this might be right for
Acute Lymphoblastic Leukemia
Dana-Farber Cancer Institute 112
Testing effectiveness (Phase 2)UnknownNCT02481310
What this trial is testing

Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma

Who this might be right for
Adult Burkitt LymphomaB-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt LymphomaDiffuse Large B-Cell Lymphoma+2 more
Northwestern University 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT02756897
What this trial is testing

Venetoclax and Ibrutinib in Treating Patients With Chronic or Small Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaRecurrent Chronic Lymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma+3 more
M.D. Anderson Cancer Center 234
Testing effectiveness (Phase 2)Active Not RecruitingNCT06035497
What this trial is testing

Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)

Who this might be right for
Relapsed or Refractory T-cell Lymphomas
Bristol-Myers Squibb 85
Testing effectiveness (Phase 2)Ended earlyNCT05272813
What this trial is testing

Investigate the Efficacy and Safety of MS-553 in CLL/SLL

Who this might be right for
Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Shenzhen MingSight Relin Pharmaceuticals Co., Ltd. 13
Early research (Phase 1)Active Not RecruitingNCT01430390
What this trial is testing

In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies

Who this might be right for
Acute Lymphocytic LeukemiaLymphoma
Memorial Sloan Kettering Cancer Center 19
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07674810
What this trial is testing

Trial Of The Combination Of Zanubrutinib, Sonrotoclax, And Obinutuzumab For Patients With Treatment-Naïve Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 40
Not applicableStudy completedNCT04172818
What this trial is testing

Feasibility Study of a Diary for Allogenic Hematopoietic Stem Cell Transplantation Patients and Families

Who this might be right for
Hematopoietic/Lymphoid CancerPsychological Disorder
Centre Hospitalier Universitaire, Amiens 20
Early research (Phase 1)Study completedNCT01373229
What this trial is testing

Lenalidomide + Plerixafor in Previously Treated Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
David Rizzieri, MD 21
Not applicableUnknownNCT05873322
What this trial is testing

Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents With ALL and Lymphoma

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-LymphomaDrug-Induced Diabetes MellitusImpaired Glucose Tolerance+1 more
Aarhus University Hospital 100
Early research (Phase 1)Study completedNCT01703572
What this trial is testing

A Dose Escalation Study of OMP-52M51 in Subjects With Lymphoid Malignancies

Who this might be right for
Relapsed or Refractory Lymphoid Malignancies
OncoMed Pharmaceuticals, Inc. 24
Not applicableStudy completedNCT01675102
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in 17p- Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
CLL
European Society for Blood and Marrow Transplantation 41
Large-scale testing (Phase 3)Active Not RecruitingNCT01886872
What this trial is testing

Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Stage I Chronic Lymphocytic LeukemiaStage II Chronic Lymphocytic LeukemiaStage III Chronic Lymphocytic Leukemia+1 more
National Cancer Institute (NCI) 547
Not applicableStudy completedNCT04872621
What this trial is testing

Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient Investigation

Who this might be right for
Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
AstraZeneca 104
Not applicableStudy completedNCT05045963
What this trial is testing

Impact of Aminoglycosides in Hypotensive Septic Oncology Patients

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmSepticemia
M.D. Anderson Cancer Center 232
Testing effectiveness (Phase 2)Study completedNCT01116193
What this trial is testing

Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic Leukemia

Who this might be right for
Leukemia, LymphoidPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma
Institut de Cancérologie de la Loire 10
Testing effectiveness (Phase 2)Study completedNCT01314014
What this trial is testing

Imexon for Relapsed Follicular and Aggressive Lymphomas

Who this might be right for
Follicular LymphomaSmall Lymphocytic LymphomaMarginal Zone Lymphoma+4 more
University of Rochester 22
Next Page